Aller au contenu principal

Let Labcorp be your source for neurodegenerative insights.

Labcorp believes in harnessing science to improve the health and lives of people with neurodegenerative diseases, such as Alzheimer’s and multiple sclerosis.

Labcorp offers comprehensive testing options across the neurodegenerative spectrum
 

Neurofilament Light Chain (NfL) Test

NfL is a well-studied blood biomarker test that is now widely available through Labcorp for assessing neuronal damage from neurodegenerative diseases and sports-related concussion.

Advancing Alzheimer's disease diagnostics

Finding a way to diagnose Alzheimer's earlier and easier is a key goal for Labcorp.

ALS / Ataxias / Huntington’s disease

Genetics can play a significant role in the development of certain neurodegenerative diseases. In some cases, genetic testing may help confirm a diagnosis.

Helping develop new biopharma breakthroughs

The increasing prevalence of neurodegenerative diseases has fueled the need for advanced research into therapeutic solutions and related neurodegenerative biomarkers.

Multiple Sclerosis (MS)

While no single test can diagnose multiple sclerosis, lab tests may help doctors rule out other diseases and confirm a diagnosis.

Muscular Dystrophy

Characterized by progressive muscle loss and weakness, our tests can detect the genetic mutations that cause the most common forms.

Glial Fibrillary Acidic Protein (GFAP)

GFAP is a protein expressed mostly in astrocytes in the brain that has utility in predicting disability progression in multiple sclerosis, determining the extent of damage in traumatic brain injury events and, in conjunction with markers of amyloid pathology, has been shown to be a predictor of Alzheimer’s disease.

About the GFAP Serum Test

About the GFAP Plasma Test

Labcorp can help meet your neurology needs

Contact a Labcorp representative to learn more about how we can help meet your neurology testing needs